|
NIH Electronic Submission
Training via Videocast
The NIH will be presenting a streaming video-cast
training session on January 11, 2006 geared toward the applicant
community providing an overview of NIH's transition plans, the submission
process and the new application form sets. The videocast will be
available to the research community as detailed below:
- Date: January 11, 2006
- Time: Session 1: 8:30AM
- 12:00PM or Session 2: 12:30PM - 4:00PM
- Location: Alumni Hall
Conference Room A
For more information, contact Sponsored Programs
Administration: (212) 263-8822.
NIH Electronic Submission Tutorial:
eSNAP/Just in Time
The Office of Sponsored
Programs Administration is pleased to present a step-by-step tutorial
on NIH's electronic submission modules: eSnap / Just in Time(JIT).
- Date: January 12, 2006
- Time: 1:00 PM - 2:00 PM
- Location: Greenberg Hall, SC1-47, Finance
Large Conference Room
For more information and to make your
reservation, contact Sponsored Programs Administration: (212) 263-8822.
- Notice Number: NOT-OD-06-014
- Key Dates: Release Date: December
1, 2005
- Issued by: National Institutes of
Health (NIH), (http://www.nih.gov)
The Department of Health
and Human Services (HHS) continues to operate on a continuing
resolution (CR) that currently extends through December 17,
2005. The CR applies the terms of the FY 2005 appropriations
for the period covered by the CR. Until the final FY 2006
appropriation is enacted, NIH will be issuing non-competing
research grant awards at a level below that indicated on the
most recent Notice of Award (generally up to 80% of the previously
committed level). NIH will consider upward adjustments to
these levels after the final appropriation is enacted, but
expects institutions to monitor their expenditures carefully
during this period.
Questions regarding adjustments
applied on individual grant awards may be directed to the
Grants Management Specialist identified on the Notice of Award.
|
National Institutes
of Health
Pilot Study to Shorten the
Review Cycle for New Investigator R01 Applications
Cognizant of the pressure on new investigators
to obtain NIH R01 funding, the Center for Scientific Review convened
a trans-NIH working group to develop a process to shorten the
referral and review cycle in order to permit a new investigator
to submit an amended application for the next submission date.
Although the number of new investigators
who will be able to take advantage of this rapid turnaround process
will be relatively small, the impact on the careers of these new
investigators could be significant. The working group recommended
an initial pilot, followed by an evaluation phase before consideration
of modification and/or expansion.
The results of this pilot will be analyzed
and a determination made as to whether to expand this to all R01
applications submitted by new investigators. Further analysis
will be done to determine if this should be expanded to all R01
applications and also to consider if other grant mechanisms should
be included. Significant expansion of this pilot will be dependent
on the full implementation of the electronic submission process.
Notices about any extensions of this pilot and any expansions
will be published in the NIH Guide for Grants and Contracts.
This pilot incorporates a number of features,
including a shortened time for reviewers to consider applications,
earlier study section meetings, accelerated production of Summary
Statements, and a delayed submission date for these amended applications.
Since NIH limits the number of resubmissions
to two, new investigators will need to consider carefully whether
this option is appropriate for their situation. Consultation with
Institute/Center program staff and senior colleagues will be important
in this process. In most cases resubmissions of R01 applications
from new investigators utilizing this accelerated process may
not be desirable.
Only R01 applications from investigators
that meet the NIH definition of new investigators that are assigned
to these study sections are included in this pilot. The Summary
Statements for these applications will include an explicit note
that identifies the application as being eligible for this pilot.
Applications submitted for the February/March
2006 dates (cycle I) will be reviewed by June 15, 2006 and Summary
Statements will be available in the NIH Commons no later than
June 20, 2006.
Should new investigators choose to participate
in this pilot, they will be able to send a resubmission application
to NIH for a special July 20, 2006 receipt date to be reviewed
at the next study section meeting in September/October 2006.
The table below shows the overall schedule
for resubmissions of new investigator R01 applications for the
three NIH submission/review/award cycles:
| |
Cycle I |
Cycle II |
Cycle III |
| New applications |
February 1 |
June 1 |
October 1 |
| Type 2 & 3, Resubmissions |
March 1 |
July 1 |
November 1 |
Resubmission R01 applications
New Investigators only for Study Sections in pilot
|
March 20 |
July 20 |
November 20 |
To qualify for this expedited resubmission
all of the following conditions must all be met:
-
The Principal Investigator
must meet the NIH definition of a new investigator.
-
A new or first resubmission
of an R01 application must be submitted for the February 1 or
March 1, 2006 date.
-
The application must be
reviewed in one of the participating Study Sections listed in
this Notice.
-
The Summary Statement must
have the special note indicating eligibility to participate
in the pilot.
-
The Principal Investigator
must determine that it is reasonable to prepare a resubmission
application in a short time.
-
The Principal Investigator
must agree that the resubmitted application be assigned to the
same Study Section; no change in review venue is permitted for
the resubmission.
-
The July 20, 2006 receipt
date must be met; late applications will not be considered.
For more information: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-06-013.html
Bristol Myers-Squibb
Distinguished Achievement
Awards
Distinguished Achievement
Awards, a component of the Bristol-Myers Squibb Freedom to Discover
Grants and Awards Program, are presented annually to individuals
for outstanding contributions in the fields of cancer, cardiovascular,
infectious diseases, metabolic diseases, neuroscience and nutrition.
Award recipients in each field receive
a $50,000 prize and a silver medallion. Independent peer-review
committees, comprised of the principal investigators of Bristol-Myers
Squibb Unrestricted Biomedical Research Grants, evaluate nominees
and select the Distinguished Achievement Award recipients.
The list below shows the type of awards
and the nomination period:
| Achievement Award |
Nomination Period |
| Cancer |
July 5, 2005 - October 31, 2005 |
| Cardiovascular |
August 8, 2005 – December 5, 2005 |
| Metabolics |
October 31, 2005 - February 27, 2006 |
| Nutrition |
October 21, 2005 - January 13, 2006 |
| Neuroscience |
November 14, 2005 - March 13, 2006 |
| Infectious Diseases |
December 5, 2005 - April 3, 2006 |
Nomination Requirements:
-
-
Abstract describing
reason for nomination (150 words)
-
Summary of the
nominee’s major contributions and impact to
the award area field of research (up to 2 pages)
-
List of up to 15
key supporting publications
-
-
Up to 5 representative
reprints (books and book chapters not
to be included)
-
Two letters of
reference from individuals outside of the nominating
institution sent directly to the Secretary of the Award Committee
no later than the award deadline listed above.
-
The Robert Wood
Johnson Clinical Scholars Program fosters the development
of leaders who will transform health and health care in this
country. These future leaders will be equipped to work with
communities and to conduct innovative research as a result
of the didactic and experiential learning they receive at
each of the four carefully chosen training sites.
-
The program’s
new focus emphasizes community-based research and leadership
training. Community-based participatory research refers to
collaboration with communities to:1) define a research issue;
2) develop a research strategy; 3) design research instruments;
and 4) work with the community to recruit subjects and collect
data (primary data collection). This also involves ongoing
feedback to the community as the data are analyzed.
-
Early contact with
Program Directors is encouraged to determine any institutional
circumstance that requires completion of the application process
in the early part of the period.
-
The application
process begins 18 months before candidates seek entrance into
the Program.
-
Appointments are
effective July 1 each year.
-
Application forms,
references, and other required documentation should be submitted
as early as possible in the application period - BUT NO LATER
THAN FEBRUARY 15, 2006 - to ensure that interviews can be
arranged and completed.
-
The application
process must be completed by April 7, 2006, including on-site
interviews at programs. Candidates are encouraged to make
inquiries and begin preliminary discussions with Program Directors
prior to this period.
Candidates will be responsible for making arrangements with
appropriate Program Directors for interviews.
-
Candidates have
the opportunity to submit revised personal statements following
the interviews. The deadline for receipt of revised statements
in the National Program Office is April 14, 2006.
-
Candidates will
be notified of the decisions on their applications between
June 15 and July 15, 2006. (The Robert Wood Johnson Foundation
does not provide critiques of applications submitted.)
Eligibility Requirements:
-
In order to be eligible
for The Robert Wood Johnson Clinical Scholars Program, physicians
may be training in any of the medical/surgical specialties;
in addition, they must:
-
Be committed to
a career consonant with the program’s purposes and priorities.
-
Be highly regarded
by those responsible for their clinical training.
-
Plan to complete
the clinical requirements of their residency/fellowship training
by the date of entry into the program (except for surgeons).
In addition, Scholars may not hold appointments as subspecialty
fellows during their tenure in the program.
-
Be U.S. citizens
or permanent residents.
-
Applicants whose
stipends will be supported or supplemented by other sources
will not be considered.
-
Stipends currently
range from $48,000 to $50,000 per year
For
more information: http://www.rwjf.org/applications/program/cfp.jsp?ID=19275
Spinal Cord Injury
Research Board
Postdoctoral Fellowships
- The intent of the Postdoctoral Fellowship
awards is to support the continued training of basic or clinical
investigators with exceptional potential for making significant
contributions to the cures of spinal cord injury (SCI) and SCI-induced
paralysis.
- Total support requested for postdoctoral
fellowships may be up to $60,000 per year for a two year period,
beginning no earlier than January 1, 2007.
Mentored Research
Scientist Development Awards/Mentored Clinical Scientist
Development Awards
- The intent of the Mentored
Research and Clinical Scientist Development Awards is
to underwrite the transition of neuroscientists and neurologists
into spinal cord injury research careers in New York institutions.
- Total support requested for
mentored scientist awards may be up to $100,000 per year
for a three year period, beginning no earlier than January
1, 2007.
- Applications may address
any topic or issue related to spinal cord injury.
- Letter of Intent Deadline:
January 25, 2006
- Application Deadline: May
17, 2006
Archives
- as of 11/25/05
|
